Beacon Capital Management Inc (Ohio)’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-5
Closed 106
2022
Q3
$0 Buy
+5
New +$363 ﹤0.01% 76
2018
Q2
Sell
-51
Closed -$2.75K 74
2018
Q1
$3K Buy
51
+37
+264% +$2.38K ﹤0.01% 60
2017
Q4
$1K Buy
+14
New +$876 ﹤0.01% 62
2017
Q2
Sell
-3
Closed 83
2017
Q1
$0 Buy
+3
New +$165 ﹤0.01% 87
2016
Q1
Sell
-5
Closed 201
2015
Q4
$0 Buy
5
+4
+400% +$264 ﹤0.01% 258
2015
Q3
$0 Buy
+1
New +$63 ﹤0.01% 244
2014
Q2
Sell
-7
Closed 229
2014
Q1
$0 Buy
+7
New +$372 ﹤0.01% 248

Other funds holding BMY

Beacon Capital Management Inc (Ohio)'s BMY Position: Q4 2022 in Review

Beacon Capital Management Inc (Ohio) sold out of Bristol-Myers Squibb (BMY) in Q4 2022, closing a stake of 5 shares.

Beacon Capital Management Inc (Ohio) first reported a position in BMY in Q1 2014 and held it in 7 quarters. The position peaked at $3K in Q1 2018. 2,600 funds tracked by Wall St. Rank hold BMY as of Q4 2022.

  • Beacon Capital Management Inc (Ohio) reported no remaining Bristol-Myers Squibb position as of Q4 2022 after selling out during the quarter.
  • Beacon Capital Management Inc (Ohio) sold 5 Bristol-Myers Squibb shares in Q4 2022.
  • Beacon Capital Management Inc (Ohio) first reported a position in Bristol-Myers Squibb in Q1 2014 and held it in 7 quarters.
  • Beacon Capital Management Inc (Ohio)'s Bristol-Myers Squibb position peaked at $3K in Q1 2018.
  • 2,600 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2022.

Based on Beacon Capital Management Inc (Ohio)'s 13F filing for Q4 2022, filed 12 Jan 2023.